Invion Limited
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also in… Read more
Invion Limited (IVIXF) - Total Liabilities
Latest total liabilities as of December 2025: $1.59 Million USD
Based on the latest financial reports, Invion Limited (IVIXF) has total liabilities worth $1.59 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Invion Limited - Total Liabilities Trend (2014–2025)
This chart illustrates how Invion Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Invion Limited Competitors by Total Liabilities
The table below lists competitors of Invion Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Antelope Enterprise Holdings Ltd
NASDAQ:AEHL
|
USA | $72.73 Million |
|
China ZhengTong Auto Services Holdings Limited
PINK:CZASF
|
USA | $25.47 Billion |
|
Royal Wins Corporation
PINK:RYWCF
|
USA | $5.24 Million |
|
CATCo Reinsurance Opps C
LSE:CATC
|
UK | $2.45 Million |
|
Silver Wolf Exploration Ltd
OTCQB:SWLFF
|
USA | $659.58K |
|
NORDSON
BE:ND1
|
Germany | €2.35 Billion |
|
Visionary Education Technology Holdings Group Inc.
NASDAQ:GV
|
USA | $58.43 Million |
|
The Calmer Co International Ltd
AU:CCO
|
Australia | AU$5.31 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Invion Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Invion Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Invion Limited (2014–2025)
The table below shows the annual total liabilities of Invion Limited from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $814.91K | -19.62% |
| 2024-06-30 | $1.01 Million | +133.97% |
| 2023-06-30 | $433.32K | +35.80% |
| 2022-06-30 | $319.07K | -50.09% |
| 2021-06-30 | $639.26K | +184.09% |
| 2020-06-30 | $225.02K | -46.97% |
| 2019-06-30 | $424.36K | -76.49% |
| 2018-06-30 | $1.80 Million | -45.17% |
| 2017-06-30 | $3.29 Million | -47.87% |
| 2016-06-30 | $6.31 Million | -31.66% |
| 2015-06-30 | $9.24 Million | +102.10% |
| 2014-06-30 | $4.57 Million | -- |